[go: up one dir, main page]

SE0300812D0 - Use of chemical compounds for preparing pharmaceutical compositions, and method of testing substances for medical effect - Google Patents

Use of chemical compounds for preparing pharmaceutical compositions, and method of testing substances for medical effect

Info

Publication number
SE0300812D0
SE0300812D0 SE0300812A SE0300812A SE0300812D0 SE 0300812 D0 SE0300812 D0 SE 0300812D0 SE 0300812 A SE0300812 A SE 0300812A SE 0300812 A SE0300812 A SE 0300812A SE 0300812 D0 SE0300812 D0 SE 0300812D0
Authority
SE
Sweden
Prior art keywords
pharmaceutical compositions
chemical compounds
preparing pharmaceutical
medical effect
inactive
Prior art date
Application number
SE0300812A
Other languages
English (en)
Inventor
Staffan Stroemblad
Wenjie Bao
Galina Selivanova
Natalia Issaeva
Original Assignee
Karolinska Innovations Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Karolinska Innovations Ab filed Critical Karolinska Innovations Ab
Priority to SE0300812A priority Critical patent/SE0300812D0/sv
Publication of SE0300812D0 publication Critical patent/SE0300812D0/sv
Priority to US10/550,516 priority patent/US20060276502A1/en
Priority to PL04723128T priority patent/PL1605939T3/pl
Priority to AU2004224488A priority patent/AU2004224488B2/en
Priority to DK04723128T priority patent/DK1605939T3/da
Priority to AT04723128T priority patent/ATE411020T1/de
Priority to ES04723128T priority patent/ES2315650T3/es
Priority to JP2006507983A priority patent/JP2006521375A/ja
Priority to PCT/SE2004/000452 priority patent/WO2004084893A1/en
Priority to NZ542212A priority patent/NZ542212A/en
Priority to DE602004017146T priority patent/DE602004017146D1/de
Priority to EP04723128A priority patent/EP1605939B1/en
Priority to CA002519795A priority patent/CA2519795A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE0300812A 2003-03-24 2003-03-24 Use of chemical compounds for preparing pharmaceutical compositions, and method of testing substances for medical effect SE0300812D0 (sv)

Priority Applications (13)

Application Number Priority Date Filing Date Title
SE0300812A SE0300812D0 (sv) 2003-03-24 2003-03-24 Use of chemical compounds for preparing pharmaceutical compositions, and method of testing substances for medical effect
US10/550,516 US20060276502A1 (en) 2003-03-24 2004-03-23 Pharmaceutical use of 1-azabicyclo[2.2.2]octanes and a method of testing compounds for the ability of activating inactive wt p53.
CA002519795A CA2519795A1 (en) 2003-03-24 2004-03-24 Pharmaceutical use of 1-azabicyclo[2.2.2]octanes and a method of testing compounds for the ability of activating inactive wt p53
DK04723128T DK1605939T3 (da) 2003-03-24 2004-03-24 Farmaceutisk anvendelse af 1-azabicyklo-2.2.2 oktaner og en fremgangsmåde til at teste forbindelser for den egenskab at aktivere inaktive WT P53
AU2004224488A AU2004224488B2 (en) 2003-03-24 2004-03-24 Pharmaceutical use of 1-azabicyclo[2.2.2]octanes and a method of testing compounds for the ability of activating inactive wt p53
PL04723128T PL1605939T3 (pl) 2003-03-24 2004-03-24 Zastosowanie farmaceutyczne 1-azabicyklo[2.2.2]oktanów i sposób testowania zdolności związków do aktywowania nieaktywnego wt p53
AT04723128T ATE411020T1 (de) 2003-03-24 2004-03-24 Pharmazeutische verwendung von 1-azabicyclo 2.2.2 octanen und verfahren zum testen von verbindungen auf die fähigkeit zur aktivierung von inaktivem wt p53
ES04723128T ES2315650T3 (es) 2003-03-24 2004-03-24 Uso farmaceutico de 1-azabiciclo-2,2,2 octanos y un metodo para ensayar compuetos con respecto a la capacidad de activar wt p53 inactivo.
JP2006507983A JP2006521375A (ja) 2003-03-24 2004-03-24 １−アザビシクロ［２．２．２］オクタンの薬剤としての使用及び不活性野生型ｐ５３を活性化する能力に関する化合物の試験方法
PCT/SE2004/000452 WO2004084893A1 (en) 2003-03-24 2004-03-24 Pharmaceutical use of 1-azabicyclo[2.2.2]octanes and a method of testing compounds for the ability of activating inactive wt p53
NZ542212A NZ542212A (en) 2003-03-24 2004-03-24 Pharmaceutical use of 1-azabicyclo[2.2.2]octanes and a method of testing compounds for the ability of activating inactive WT P53
DE602004017146T DE602004017146D1 (de) 2003-03-24 2004-03-24 PHARMAZEUTISCHE VERWENDUNG VON 1-AZABICYCLOi 2.2.2 OCTANEN UND VERFAHREN ZUM TESTEN VON VERBINDUNGEN AUF DIE FÄHIGKEIT ZUR AKTIVIERUNG VON INAKTIVEM WT P53
EP04723128A EP1605939B1 (en) 2003-03-24 2004-03-24 Pharmaceutical use of 1-azabicyclo¬ 2.2.2 octanes and a method of testing compounds for the ability of activating inactive wt p53

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0300812A SE0300812D0 (sv) 2003-03-24 2003-03-24 Use of chemical compounds for preparing pharmaceutical compositions, and method of testing substances for medical effect

Publications (1)

Publication Number Publication Date
SE0300812D0 true SE0300812D0 (sv) 2003-03-24

Family

ID=20290771

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0300812A SE0300812D0 (sv) 2003-03-24 2003-03-24 Use of chemical compounds for preparing pharmaceutical compositions, and method of testing substances for medical effect

Country Status (2)

Country Link
US (1) US20060276502A1 (sv)
SE (1) SE0300812D0 (sv)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0400708D0 (sv) 2004-03-22 2004-03-22 Aprea Ab New compounds and use thereof
AU2016288230A1 (en) 2015-07-02 2018-01-25 Horizon Orphan Llc ADO-resistant cysteamine analogs and uses thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6921765B2 (en) * 2000-09-20 2005-07-26 Aprea Ab 1-Azabicyclo[2.2.2]octan-3-one derivatives and maleimide derivatives and their use for treating cancer tumors

Also Published As

Publication number Publication date
US20060276502A1 (en) 2006-12-07

Similar Documents

Publication Publication Date Title
DE60029799D1 (de) Verbindungen, verfahren und pharmazeutische zubereitungen zur behandlung von zellschäden wie zum beispiel schäden an nerven- oder kerzgefässgewebe
ATE329897T1 (de) Verbindungen und zusammensetzungen zur verabreichung aktiven substanzen
EP1226109A4 (en) PHENYLAMINE CARBOXYLIC ACID COMPOUNDS AND COMPOSITIONS FOR DISPENSING ACTIVE AGENTS
ATE391708T1 (de) Verbindungen und gemische zur verabreichung eines aktiven agens
ATE269846T1 (de) N-substituierte aminotetraline als neuropeptid y y5 rezeptor-liganden und ihre anwendung zur behandlung von fettleibigkeit und anderen erkrankungen
BRPI0416752A (pt) composição farmacêutica, uso de um ou mais compostos, método para a prevenção ou tratamento de distúrbios, compostos, e, processo para a preparação de uma composição farmacêutica
DE60043587D1 (de) Mittel für erkrankungen assoziert mit knochensubstanzverlust
HUP0102515A2 (hu) Ciklopeptidek, eljárás előállításukra, hatóanyagként azokat tartalmazó gyógyszerkészítmények és alkalmazásuk
ATE470443T1 (de) Indol-1-yl-essigsäurederivate
DE60112766D1 (de) Verwendung von derivaten der valproinsäureamide und 2-valproinsäureamid zur behandlung und prävention von schmerzen und/oder kopfschmerzen
DK1296972T3 (da) Arylmethylamin-derivater til anvendelse som tryptaseinhibitorer
PL1605939T3 (pl) Zastosowanie farmaceutyczne 1-azabicyklo[2.2.2]oktanów i sposób testowania zdolności związków do aktywowania nieaktywnego wt p53
NO20022589L (no) Anti-picornavirus-forbindelser og -preparater, deres farmasöytiske anvendelse og materialer for syntese av dem
PL352476A1 (en) Novel derivatives of piperazinylalkylthiopyrimidine, parmacological compositions containing tese compounds and method of obtaining active substance
ATE355054T1 (de) Verfahren und verbindungen zur behandlung der depression
NO20055623L (no) Azabicyklononenderivater
ATE290857T1 (de) Bretyliumhaltige zusammensetzungen und kits und deren verwendung zur vorbeugung und behandlung cardiovaskulärer erkrankungen
SE0300812D0 (sv) Use of chemical compounds for preparing pharmaceutical compositions, and method of testing substances for medical effect
ATE373000T1 (de) Pyrazolopyridin-derivate als antiherpesmittel
ATE254122T1 (de) Indolderivate als 5-ht1b und 5-ht1d agonisten
WO2006081997A3 (de) Isolierung von atrarsäure, synthese von atrarsäure-derivaten sowie verwendung der atrarsäure und ihrer derivate zur behandlung der benignen prostatahyperplasie, des prostatakarzinoms und der spinobulbären muskelatrophie
DE60041137D1 (de) Ceramid ähnliche verbindungen, verfahren zu deren herstellung und deren verwendung als antitumormittel
FR2860234B1 (fr) Nouveaux derives 666 du thioxylose
DE602004016841D1 (de) Verwendung von 2,2,3,3, tetramethylcyclopropane carbonsäure derivaten zur behandlung von psychiatrischen störungen
MY141756A (en) Use of phenoxyacetic acid derivatives for treating hyperactive bladder